The African Footprint: How the continent's preparedness impacts the rest of the world

COVID-19 Valerie Nkamgang Bemo

Read next

Laboratory worker prepares test tubes

ReFRAMing Research: How new technology could reveal a treatment for COVID-19

Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation's Discovery & Translational Sciences team.
Ken Duncan Deputy Director, Drug Discovery, Bill & Melinda Gates Foundation
Announcing the therapeutics accelerator

Announcing the COVID-19 Therapeutics Accelerator

We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The expertise of pharmaceutical companies will be critical to this endeavor, named the COVID-19 Therapeutics Accelerator
Mark Suzman CEO, Board Member, Bill & Melinda Gates Foundation